• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡托普利、可还原卡托普利结合物及S-甲基卡托普利在大鼠体内的组织分布

Tissue distribution of captopril, reducible captopril conjugates and S-methylcaptopril in the rat.

作者信息

Drummer O H, Worland P J, Jarrott B

出版信息

Biochem Pharmacol. 1983 May 15;32(10):1563-8. doi: 10.1016/0006-2952(83)90328-3.

DOI:10.1016/0006-2952(83)90328-3
PMID:6344870
Abstract

The tissue distribution of captopril, an antihypertensive drug possessing a free sulfhydryl group, and its sulfur-conjugated metabolites was studied in rats by gas chromatography-mass spectrometry at 15, 30 and 60 min following a single 10 mg/kg oral dose of captopril. It was found that tissue accumulation of captopril was rapid with both free and oxidized-forms already present at 15 min post-dose. A maximum concentration of captopril was achieved at 30 min in tissues studied, being substantially higher in kidney (14.2 micrograms/g), with lesser amounts occurring in liver, lung, heart, blood cells, spleen and plasma in that order. Oxidized disulfide forms of captopril were usually present in the same or slightly higher proportion than free captopril except for liver which only contained detectable disulfides at 15 min after oral dosing. S-methylcaptopril was also present at 30 min in all tissues examined with highest levels occurring in liver and kidney (1.05 micrograms/g) followed by plasma, lung, heart, spleen and blood cells.

摘要

采用气相色谱-质谱联用技术,在大鼠单次口服10mg/kg卡托普利后15、30和60分钟,研究了具有游离巯基的抗高血压药物卡托普利及其硫结合代谢物的组织分布。结果发现,卡托普利在组织中的蓄积迅速,给药后15分钟时游离型和氧化型均已存在。在所研究的组织中,卡托普利在30分钟时达到最高浓度,肾脏中浓度最高(14.2微克/克),其次是肝脏、肺、心脏、血细胞、脾脏和血浆,浓度依次降低。除肝脏外,卡托普利的氧化二硫形式通常以与游离卡托普利相同或略高的比例存在,肝脏在口服给药后15分钟仅含有可检测到的二硫化物。在给药30分钟时,所有检测组织中均存在S-甲基卡托普利,肝脏和肾脏中含量最高(1.05微克/克),其次是血浆、肺、心脏、脾脏和血细胞。

相似文献

1
Tissue distribution of captopril, reducible captopril conjugates and S-methylcaptopril in the rat.卡托普利、可还原卡托普利结合物及S-甲基卡托普利在大鼠体内的组织分布
Biochem Pharmacol. 1983 May 15;32(10):1563-8. doi: 10.1016/0006-2952(83)90328-3.
2
S-methylation of captopril. Demonstration of captopril thiol methyltransferase activity in human erythrocytes and enzyme distribution in rat tissues.卡托普利的S-甲基化。人红细胞中卡托普利硫醇甲基转移酶活性的证明及大鼠组织中的酶分布
Biochem Pharmacol. 1983 May 15;32(10):1557-62. doi: 10.1016/0006-2952(83)90327-1.
3
Captopril disulfide conjugates may act as prodrugs: disposition of the disulfide dimer of captopril in the rat.
Biochem Pharmacol. 1984 Nov 15;33(22):3567-71. doi: 10.1016/0006-2952(84)90138-2.
4
Disposition and metabolism of the novel antihypertensive agent alacepril in rats.
Arzneimittelforschung. 1986;36(1):40-6.
5
Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine.
J Chromatogr. 1984 Jan 13;305(1):83-93. doi: 10.1016/s0378-4347(00)83316-2.
6
Demonstration of a S-methyl metabolite of captopril in patients undergoing chronic captopril therapy.慢性卡托普利治疗患者中卡托普利 S-甲基代谢物的证实。
Clin Exp Pharmacol Physiol Suppl. 1982;7:81-6.
7
Captopril: pharmacology, metabolism and disposition.卡托普利:药理学、代谢与处置
Drug Metab Rev. 1984;15(4):841-69. doi: 10.3109/03602538409041080.
8
Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats.新型抗高血压药物阿拉普利在肾性高血压大鼠中的组织水平、组织血管紧张素转换酶抑制作用及降压效果
Arzneimittelforschung. 1986;36(1):47-51.
9
Drug protein conjugates--I. A study of the covalent binding of [14C]captopril to plasma proteins in the rat.
Biochem Pharmacol. 1982 May 1;31(9):1755-60. doi: 10.1016/0006-2952(82)90680-3.
10
In vitro studies on the metabolic pathway of SQ 14225 (Captopril) and mechanism of mixed disulfide formation.关于SQ 14225(卡托普利)代谢途径及混合二硫键形成机制的体外研究
J Pharmacobiodyn. 1981 Sep;4(9):677-84. doi: 10.1248/bpb1978.4.677.

引用本文的文献

1
The pharmacokinetics of captopril and captopril disulfide conjugates in uraemic patients on maintenance dialysis: comparison with patients with normal renal function.卡托普利及其二硫化物共轭物在维持性透析的尿毒症患者中的药代动力学:与肾功能正常患者的比较。
Eur J Clin Pharmacol. 1987;32(3):267-71. doi: 10.1007/BF00607574.
2
Lisinopril pharmacokinetics in chronic renal failure.赖诺普利在慢性肾衰竭中的药代动力学。
Br J Clin Pharmacol. 1988 Jun;25(6):719-24. doi: 10.1111/j.1365-2125.1988.tb05258.x.